SynerFuse™ Announces New Team Members
MINNEAPOLIS – May 27, 2021 – SynerFuse, Inc., a Minneapolis-based medical device company, is pleased to announce the addition of new members to the SynerFuse team, bringing legal, marketing, and executive management experience to the company:
Dennis McFadden, MBA – Chief Financial Officer
Mr. McFadden has extensive corporate finance and corporate development experience in both multinational and startup companies where he has served as a C-level or senior financial executive or board member. McFadden has broad experience in the medical device industry, where he has raised public and private debt and equity funding, engaged in numerous buy-side and sell-side M&A transactions, as well as a variety of corporate development/licensing arrangements. He currently serves on the board of directors at Protégé Biomedical. Mr. McFadden holds a degree in finance and an MBA, both from the University of St. Thomas.John Cameron, JD, General Counsel and Secretary to the Board
Mr. Cameron received his law degree from William Mitchell School of Law in 1991 and has a B.A. in business administration and finance from the University of St. Thomas. He opened his own law practice in 1992, starting with commercial and employment litigation. Mr. Cameron now includes advising corporations and entrepreneurs in their business endeavors.Michael Brice, VP of Legal
Mr. Brice integrates business initiatives related to risk, compliance, and strategic operations. Before his current role, Mr. Brice has held positions such as chief operating officer, director of business development, and spent several years practicing law related to business litigation and marital estates. He holds a bachelor’s degree in special education and teaching from the University of Wisconsin – Madison and earned his law degree at the University of Wisconsin Law School.Matt Stoll, Director of Marketing
Mr. Stoll has successfully launched and managed multiple products in both the medical device and telecommunications industries in small- and mid-sized business environments. In his 20-year career in product management and marketing, he has acquired extensive experience successfully leading cross-functional marketing and development teams in new product development. During his career in the medical device space, Mr. Stoll has actively raised and managed more than $20M in non-dilutive funding through the NIH SBIR program. Mr. Stoll has a bachelor’s degree in electrical engineering from Penn State University and an MBA from the University of Minnesota.
About Chronic Lower Back Pain (CLBP)
CLBP is defined as pain that continues for 12 weeks or longer, even after an initial injury or underlying cause of acute lower back pain has been treated. With 500,000 procedures performed annually, spinal fusion remains a common treatment for spinal instability, albeit with a high incidence of residual neuropathic pain. The continuum of increasingly ineffective opioid treatments, additional interventions and adjacent level spinal fusions leaves up to 46% of patients with significant, lingering pain, costing the U.S. healthcare system $20B per year and significantly affecting the quality of life of patients.
About SynerFuse
SynerFuse is a Delaware corporation based in Minnesota—the heart of Medical Alley. SynerFuse believes that individuals with chronic back pain and their providers deserve a better option than spinal fusion alone. Even when spinal fusion is successful, it can often result in residual chronic pain and use of addictive opioids. The company is working to create a new future of non-narcotic pain management for lower back pain with a patented therapy that integrates spinal fusion hardware, an active neuromodulation system, and sensors in a novel "smart" device.